ARCHIVES

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

Rogers Subcommittee Rewrite Cancer Control Definition, Adds $45 Million Over Three Years

April 21, 1978

Non-Chemo Agents Added To Regimens For Lymphomas

January 26, 2007

NCAB Asks Government To Take Steps Aimed at Reducing Health Hazards From Cigarettes

December 21, 1973

MGMT Gene Can Determine Disease Aggressiveness

June 24, 2011

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

June 27, 2008

Senate Approves $47 Million For More AIDs Drugs

September 19, 1986